| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 7 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 2 | TACROLIMUS OINTMENT 0.1% | 6 |
| 3 | AZACITIDINE | 4 |
| 4 | AZACITIDINE FOR | 4 |
| 5 | GILTERITINIB | 4 |
| 6 | MYCOPHENOLATE MOFETIL | 3 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 8 | PREDNISONE | 3 |
| 9 | FLUCONAZOLE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GILTERITINIB | 4 | 0.0010 |
| 1 | AZACITIDINE | 4 | 0.0001 |
| 2 | GANCICLOVIR SODIUM | 1 | 0.0001 |
| 3 | BASILIXIMAB | 1 | 0.0001 |
| 4 | TACROLIMUS OINTMENT 0.1% | 6 | 0.0000 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 | 0.0000 |
| 6 | TACROLIMUS | 7 | 0.0000 |
| 7 | FLUCONAZOLE | 2 | 0.0000 |
| 8 | MYCOPHENOLATE MOFETIL | 3 | 0.0000 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 3 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 4 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 3 | 0.0000 |
| 6 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |